Committed to your health

 

Drug Recalls

Your safety is our #1 priority. From time to time, certain prescription medications dispensed by Kinney Drugs may be recalled by the manufacturer(s). When this happens, we will display details on the recall(s), along with any instructions provided by the manufacturer(s) . 

 

September 19th, 2025 - 

 

SUPPLIER:                                              Dr. Reddy’s - 19991

 

Description

Lot #

Exp Date

NDC #

UPC #

Econo #

ROPINIR XR TAB 2MG DR/R 90@

C2315044

9/30/2025

55111065990

35511165990

1176908

ROPINIR XR TAB 2MG DR/R 30@

C2315045

9/30/2026

55111065930

35511165930

1176098

 

Event Description:

Dr. Reddy’s is voluntarily withdrawing the above items/lots due to the Out of Trend result observed during the 18-month stability review of related substance data. This withdrawal is to the Consumer level. Affected product started shipping December 15, 2023.

 

Consumer Information:

Patients should contact their doctor or health care provider for medical-related questions.

June 4th, 2025 -

 

LEVEL OF NOTIFICATION:                 Consumer

SUPPLIER:                                              Amneal - # 12853

 

Description

Lot #

Exp Date

NDC #

UPC #

Econo #

SULFAM+TRI TB 400/80MG AMN100@

AM241019

6/30/2027

65162027110

36516227110

3990959

AM241020

6/30/2027

SULFAM+TRI TB400/80MG AMN 500@

AM241019A

6/30/2027

65162027150

36516227150

3990967

 

Event Description:

Amneal is voluntarily recalling the above items/lots due to tablets that may exhibit black spots due to microbial contamination. This recall is to the Consumer level. Affected product started shipping December 4, 2024.

 

Consumer Information:

Patients should contact their doctor or health care provider for medical-related questions.

 

May 28th, 2025 -

 

LEVEL OF NOTIFICATION:                 Consumer

SUPPLIER:                                              Teva- # 26108

 

Description

Lot #

Exp Date

NDC #

UPC #

Econo #

METOCLOPR TAB 10MG TEV 100@

5420094

9/30/2027

93220301

30093220301

1813708

 

Event Description:

Teva is voluntarily recalling the above item/lot due to a single Torsemide Tablet (20mg) was discovered in each of three sealed bottles of Metoclopramide tablets. This recall is to the Consumer level. Affected product started shipping December 16, 2024.

 

Consumer Information:

Patients should contact their doctor or health care provider for medical-related questions.

May 16th, 2025 - 

 

URGENT: Medical Device Correction

Dexcom G6 Receive - MT27408-1, Dexcom G7 Receive - MT26403-0

 

Part Number SKUs Part Description
MT27408-1 STK-FE-001, STK-FM-001, STK-FR-001 Dexcom G6 Receiver
MT26403-0 STK-AT-011, STK-AT-012, STK-AT-013 Dexcom G7 Receiver

 

Description of the Problem:

Users of the Dexcom G6 or G7 Receiver have reported an issue in which the receiver may not provide audio output to alerts/alarms as expected.

April 30th, 2025 - 

FDA/SUPPLIER CLASS OF RECALL:   Not Yet Classified

LEVEL OF NOTIFICATION:                 Consumer

SUPPLIER:                                              AVKARE - # 04522, 04582

 

Description

Lot #

Exp Date

NDC #

Econo #

ARTIFICIAL TEAR OPH/O AVK 15ML

126

10/26/2025

50268004315

2821411

127

10/30/2025

128

11/2/2025

129

11/6/2025

162

5/9/2026

163

5/14/2026

164

5/20/2026

165

5/23/2026

166

5/29/2026

167

6/3/2026

168

6/6/2026

169

6/10/2026

170

6/13/2026

193

10/7/2026

194

10/10/2026

195

10/14/2026

196

10/17/2026

197

10/21/2026

198

10/24/2026

199

10/30/2026

CARBOXY SOD OPH GEL 1% AVK15ML

114

9/4/2025

50268006615

2635233

115

9/6/2025

116

9/10/2025

207

12/5/2026

CARBOXYM SOD OP/S 0.5%AVK15ML@

103

4/26/2025

50268006815

2304061

104

5/3/2025

108

6/29/2025

109

7/18/2025

110

8/17/2025

111

8/22/2025

112

8/27/2025

113

9/18/2025

125

10/23/2025

130

11/9/2025

131

11/14/2025

132

11/27/2025

133

11/30/2025

134

12/5/2025

135

12/11/2025

136

12/14/2025

137

1/2/2026

139

1/15/2026

140

1/19/2026

141

1/25/2026

151

3/18/2026

152

3/21/2026

153

3/25/2026

154

3/28/2026

155

4/8/2026

156

4/8/2026

157

4/11/2026

160

4/26/2026

180

8/8/2026

181

8/12/2026

182

8/18/2026

183

8/21/2026

184

8/26/2026

185

9/4/2026

186

9/9/2026

187

9/16/2026

189

9/21/2026

190

9/25/2026

191

9/28/2026

192

10/2/2026

208

12/11/2026

209

12/16/2026

212

1/15/2027

213

1/21/2027

214

1/24/2027

215

2/2/2027

216

2/4/2027

224

3/27/2027

POLYET GLY OPT SOL400 AVK 15ML

117

9/20/2025

50268012615

2823375

118

9/25/2025

119

9/27/2025

121

10/5/2025

161

5/1/2026

171

6/18/2026

172

6/24/2026

174

7/1/2026

175

7/8/2026

200

11/5/2026

201

11/10/2026

202

11/13/2026

203

11/18/2026

204

11/21/2026

205

11/25/2026

206

12/2/2026

219

2/24/2027

221

3/2/2027

222

3/5/2027

POLYVINYL OPH/SOL 1.4% AVK15ML

120

10/2/2025

50268067815

2821429

122

10/9/2025

123

10/12/2025

124

10/16/2025

138

10/8/2026

142

12/9/2026

143

2/1/2026

144

2/7/2026

145

2/12/2026

146

2/15/2026

147

2/21/2026

148

2/27/2026

149

3/4/2026

150

3/11/2026

158

4/15/2026

159

4/22/2026

176

7/24/2026

177

7/28/2026

178

7/31/2026

179

8/5/2026

 

 

Event Description:

AVKARE is voluntarily recalling the above items/lots due to manufacturing cGMP deviations identified during an audit by the FDA. This recall is to the Consumer level. Affected product started shipping May 26, 2023.

 

Consumer Information:

Patients should contact their doctor or health care provider for medical-related questions.

March 14th, 2025 - 

LEVEL OF NOTIFICATION: Consumer

SUPPLIER: Exela - # 15287

 

Description

Lot #

Exp Date

NDC #

UPC #

Econo #

SOD BIC SDV 50MEQ/50ML EXE 25@

10006417

10/1/2026

51754500104

35175450014

2630101

10006418

10/1/2026

 

Event Description:

Exela is voluntarily recalling the above item/lots due to the complaints that some vials had an insufficient crimp on the cap and stopper which may expose the rug product to the environment and could potentially impact the sterility and purity of the product. This recall is to the Consumer level. Affected product started shipping February 5, 2025.

 

Consumer Information:

Patients should contact their doctor or health care provider for medical-related questions.

February 14th, 2025 - 

 

FDA/SUPPLIER CLASS OF RECALL:   Class II

LEVEL OF NOTIFICATION:                 Consumer

SUPPLIER:                                              BRP - # 50703,7947

 

Description

Lot #

Exp Date

NDC #

UPC #

McKesson Item Number

MORPH SULF ER TB 100MG SUN100@

AD16615

7/31/2025

63304045201

36330445201

3491180

MORPH SULF ER TB 100MG BRP 100

244480

7/31/2025

72162179101

37216217911

2969400

241711

7/31/2025

247364

7/31/2025

239789

7/31/2025

248226

7/31/2025

239878

7/31/2025

 

Event Description:

BRP is voluntarily recalling the above items/lots due to Out of Specification (OOS) results observed in dissolution test for Morphine Sulfate Extended-Release Tablets, 100 mg Batch AD16615, during analysis at 12 month long term stability station (25*C, 60%RH).  This recall is to the Consumer level. Affected product started shipping June 7, 2024.

 

Consumer Information:

Please contact your healthcare provider for any medical related questions. 

FDA/SUPPLIER CLASS OF RECALL:   Not Yet Classified

LEVEL OF NOTIFICATION:                 Consumer

SUPPLIER:                                              Alvogen - # 25804

 

Description

Lot #

Exp Date

NDC #

Econo #

FENTANY TDS MTX 25MCG/HR ALV5@

108319

4/30/2027

47781042447

3620994

 

Event Description:

Alvogen is voluntarily recalling the above item/lot due to the possibility that the application of a multi stacked 25mcg/h patch could result in serious, life threatening, or fatal respirator depression. This recall is to the Consumer level. Affected product started shipping June 11, 2024. Please note NDC 47781-424-11 on the notification is the inner pouch NDC. The carton NDC is 47781-424-47.

 

Consumer Information:

Prior to returning, please consult with your pharmacist, who can advise you about replacement medication or reimbursement. Please also consult with your healthcare provider or physician.